Hardcover
Master drug combination analysis: precise design, robust statistical methods.
Save 15%
Pre-Order

Evaluating Synergy

Statistical Design and Analysis of Drug Combination Studies

RRP$134.94

$114.70

  • Hardcover

    256 pages

  • Release Date

    2 February 2027

Check Delivery Options

Summary

Design and analyze drug combination studies with statistical precision

Identifying synergistic drug combinations requires rigorous statistical methodology to distinguish true interactions from simple additivity. Evaluating Synergy: Statistical Design and Analysis of Drug Combination Studies presents modern methods for optimally designing and analyzing combination studies in cancer, antiviral, and other therapeutic areas. Written by biostatisticians and a phys…

Book Details

ISBN-13:9780470669693
ISBN-10:0470669691
Author:Ming Tan, Hongbin Fang, Douglas Ross
Publisher:John Wiley & Sons Inc
Imprint:John Wiley & Sons Inc
Format:Hardcover
Number of Pages:256
Release Date:2 February 2027
Dimensions:168mm x 244mm
Series:Statistics in Practice
A-Format
B-Format
C-Format
Evaluating Synergy by Ming Tan - ISBN: 9780470669693
168 × 244 mm
A4
mm / in
About The Author

Ming Tan

Ming T. Tan is a professor in the Department of Biostatistics, Bioinformatics, and Biomathematics at Georgetown University School of Medicine and Georgetown Lombardi Comprehensive Cancer Centre, and a Fellow of the American Statistical Association. He has published more than 250 articles, numerous book chapters, and a book on statistical methods in biomedical research. He has previously held positions at the Cleveland Clinic, St. Jude Children’s Research Hospital, and the University of Maryland School of Medicine.

Hong-Bin Fang is an Associate Professor in the Department of Biostatistics, Bioinformatics, and Biomathematics at Georgetown University School of Medicine and the Lombardi Comprehensive Cancer Center. He has more than twenty years of experience in statistical design and analysis of cancer research studies, focusing on preclinical models, drug combinations, and high-dimensional genomic data.

Douglas D. Ross, MD, PhD, is Professor of Medicine, Pathology, Pharmacology, and Experimental Therapeutics and former Director of the Program in Experimental Therapeutics at the University of Maryland School of Medicine. He is a board-certified medical oncologist recognized worldwide for his work in mechanisms of drug action and drug resistance.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.